Camela E - Search Results

1

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?

Megna M, Camela E, Ruggiero A, Battista T, Martora F, Cacciapuoti S, Potestio L. Megna M, et al. Among authors: camela e. Clin Cosmet Investig Dermatol. 2023 Jun 28;16:1677-1690. doi: 10.2147/CCID.S407812. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37404368 Free PMC article. Review.

2

A case of erythrodermic psoriasis successfully treated with guselkumab.

Megna M, Ruggiero A, Camela E, Fabbrocini G, Marasca C. Megna M, et al. Among authors: camela e. Dermatol Ther. 2020 Mar;33(2):e13238. doi: 10.1111/dth.13238. Epub 2020 Feb 6. Dermatol Ther. 2020. PMID: 31997488

3

Apremilast efficacy and safety in elderly psoriasis patients over a 48-week period.

Megna M, Fabbrocini G, Camela E, Cinelli E. Megna M, et al. Among authors: camela e. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e705-e707. doi: 10.1111/jdv.16443. Epub 2020 Jul 28. J Eur Acad Dermatol Venereol. 2020. PMID: 32277507 No abstract available.

4

Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis?

Megna M, Marasca C, Ruggiero A, Camela E, Fabbrocini G. Megna M, et al. Among authors: camela e. Int J Dermatol. 2020 Aug;59(8):e308-e309. doi: 10.1111/ijd.14902. Epub 2020 May 2. Int J Dermatol. 2020. PMID: 32358963 No abstract available.

5

Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period.

Megna M, Camela E, Cinelli E, Fabbrocini G. Megna M, et al. Among authors: camela e. Clin Exp Dermatol. 2020 Oct;45(7):848-852. doi: 10.1111/ced.14258. Epub 2020 Jun 2. Clin Exp Dermatol. 2020. PMID: 32363583

6

Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data.

Megna M, Cinelli E, Camela E, Fabbrocini G. Megna M, et al. Among authors: camela e. Expert Rev Clin Immunol. 2020 Jun;16(6):599-620. doi: 10.1080/1744666X.2020.1776116. Epub 2020 Jun 22. Expert Rev Clin Immunol. 2020. PMID: 32476507 Review.

7

Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience.

Megna M, Fabbrocini G, Cinelli E, Camela E, Ruggiero A. Megna M, et al. Among authors: camela e. J Dermatolog Treat. 2022 Mar;33(2):1074-1078. doi: 10.1080/09546634.2020.1800577. Epub 2020 Aug 4. J Dermatolog Treat. 2022. PMID: 32705907 Free article.

8

Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.

Camela E, Miano C, Di Caterino P, Lo Presti M, De Fata Salvatores G, Fabbrocini G, Megna M. Camela E, et al. Dermatol Ther. 2020 Nov;33(6):e14223. doi: 10.1111/dth.14223. Epub 2020 Sep 9. Dermatol Ther. 2020. PMID: 32820849 Review.

9

Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II.

Camela E, Fabbrocini G, Cinelli E, Lauro W, Megna M. Camela E, et al. Dermatology. 2021;237(1):13-14. doi: 10.1159/000513575. Epub 2020 Dec 9. Dermatology. 2021. PMID: 33296899 Free PMC article. No abstract available.

10

Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review.

Camela E, Ocampo-Garza SS, Cinelli E, Villani A, Fabbrocini G, Megna M. Camela E, et al. Dermatol Ther. 2021 Mar;34(2):e14857. doi: 10.1111/dth.14857. Epub 2021 Feb 17. Dermatol Ther. 2021. PMID: 33559275 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters